Dose boundary: trials tested acetyl-L-carnitine at 500 mg/day or 1,000 mg/day total (each given in divided doses three times daily), not the card's 500 mg twice-daily schedule. The 1,000 mg/day arm's total daily amount matches the card's regimen (500 mg b.i.d. = 1,000 mg/day) — only the administration split (t.i.d. vs. b.i.d.) differs.
We evaluated frozen databases from two 52-week randomized placebo-controlled clinical diabetic neuropathy trials testing two doses of acetyl-L-carnitine (ALC): 500 and 1,000 mg/day t.i.d.
Evidence scope. Human, diabetic peripheral neuropathy patients; oral, 500 or 1,000 mg/day TOTAL (t.i.d. split), 52-week trials.